Grants and Contributions:
Title:
Evaluation tests of silica spheres intended for the transport of therapeutic agents.
Agreement Number:
936021
Agreement Value:
$99,900.00
Agreement Date:
Oct 7, 2019 - Mar 27, 2020
Description:
As part of the development of a therapeutic nano-vecteur for the improvement of chemotherapy, development of laboratory validation tests to evaluate the physicochemical behaviour of this nano-vecteur once in contact with the body.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4S6
Reference Number:
172-2019-2020-Q3-936021
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
743257313
Recipient Type:
For-profit organization
Recipient's Legal Name:
Pharma In Silica inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410